Sun Pharmaceutical Industries
SUNPHARMA
Sun Pharmaceutical Industries Market Sentiment
| Timeline | Returns | Volume |
|---|---|---|
| Daily | 5.05% | 30,99,257 |
| Weekly | 9.80% | 54,43,320 |
| Monthly | 13.52% | 1,73,05,308 |
Sun Pharmaceutical Industries Performance
| Timeline | Daily | Weekly | Monthly |
|---|---|---|---|
| SUNPHARMA | 5.05% | 9.80% | 13.52% |
| Index | - | - | - |
| Peer Avg. | 1.75% | 5.43% | 11.19% |
Sun Pharmaceutical Industries Fundamentals
| Timeline | PE | PB | EV/EBIDTA | ROE | ROCE | Div. Yield |
|---|---|---|---|---|---|---|
| SUNPHARMA | 67.07 | 6.75 | 21.51 | 3.41 | 5.72 | 0.97 |
| Index | 36.20 | 6.77 | 17.25 | 17.89 | 19.69 | 1.20 |
| Peer Avg. | 39.55 | 4.75 | 12.35 | 13.59 | 17.02 | 0.87 |
Sun Pharmaceutical Industries Key Metrics
| Metrics | Sales Growth | Profit Growth | ROE | ROCE |
|---|---|---|---|---|
| FY '21-22 | 12.90% | -31.40% | 3.41% | 5.72% |
| FY '20-21 | 7.33% | -59.60% | 4.13% | 4.56% |
| FY '19-20 | 17.30% | 161.85% | 11.63% | 11.13% |
Sun Pharmaceutical Industries Shareholding Pattern
Sun Pharmaceutical Industries Profit & Loss
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| FY '21-22 | 27,120.24 | 20,845.05 | 7,592.34 | 1,652.91 |
| FY '20-21 | 23,807.10 | 18,444.73 | 5,887.98 | 1,563.54 |
| FY '19-20 | 22,684.72 | 17,841.81 | 5,924.15 | 3,698.97 |
Sun Pharmaceutical Industries Peer Comparison
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| SUNPHARMA | 27,120.24 | 20,845.05 | 7,592.34 | 1,652.91 |
| BAJAJFINSV | 34,514.96 | 23,568.71 | 11,015.28 | 4,368.88 |
| DMART | 30,664.38 | 28,164.38 | 2,629.19 | 1,554.29 |
Sun Pharmaceutical Industries Share Price
Sun Pharmaceutical Industries Limited is a company specialised in the production of generic drugs. The field of activity of the company is the production, development and marketing of various generic preparations. It produces a range of generic and specialty medicines targeting a wide range of chronic and acute treatments. The company's product portfolio includes generics, branded generics, specialty products, OTC/consumer health products, antiretrovirals (ARVs), active pharmaceutical ingredients (APIs) and intermediates. Its OTC brands include Faringosept, Revital and Volini. The company offers its products in several different dosage forms such as tablets, capsules, sprays, injections, inhalers, ointments, creams and liquids. Its special product portfolio, generic brands are available in 100 countries. The company has production facilities on 6 continents.